Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-10

Clinical Trial Update: Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial exploring pre-surgical treatment with carboplatin and an albumin-stabilized nanoparticle formulation of paclitaxel in patients with locally adva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • Paclitaxel Albumin-Stabilized Nanoparticle Formulation (paclitaxel)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Inflammatory Breast Cancer, Stage IIA Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-03-10